Misoprostol: A quarter century of use, abuse, and creative misuse

被引:37
作者
Chong, YS
Su, LL
Arulkumaran, S
机构
[1] St George Hosp, Sch Med, Dept Obstet & Gynaecol, London SW17 0RE, England
[2] Natl Univ Singapore, Dept Obstet & Gynaecol, Singapore 117548, Singapore
关键词
D O I
10.1097/01.OGX.0000109168.83489.66
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Misoprostol is a prostaglandin El analog originally intended for use to prevent NSAID-induced gastric ulcers. However, because of its cervical ripening and uterotonic property, misoprostol has become one of the most useful drugs in obstetrics and gynecology. Misoprostol has proven to be a very convenient and flexible drug because of its formulation as a tablet that is stable and that can be administered orally, rectally, vaginally and by the sublingual route. Beginning with its abuse for illegal abortion in the late 1980s, misoprostol has quickly become established as one of the most effective drugs for terminating pregnancies in the first and second trimesters, as well as for inducing labor in the third trimester. Its use for routine prevention of postpartum hemorrhage has not been so successful, partly as the high doses required for this indication often result in troublesome side effects. Despite the large body of medical evidence about its efficacy and relative safety, the use of misoprostol in pregnant women remained off-label until the spring of 2002.
引用
收藏
页码:128 / 140
页数:13
相关论文
共 140 条
[1]  
*A GUTTM I, 2003, FACTS BRIEF IND AB W
[2]   The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration [J].
Abdel-Aleem, H ;
Villar, J ;
Gülmezoglu, AM ;
Mostafa, SA ;
Youssef, AA ;
Shokry, M ;
Watzer, B .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2003, 108 (01) :25-28
[3]   A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section [J].
Acharya, G ;
Al-Sammarai, MT ;
Patel, N ;
Al-Habib, A ;
Kiserud, T .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2001, 80 (03) :245-250
[4]  
ACOG, 1999, ACOG PRACT B
[5]  
*ACOG COMM, 2003, NEW US FOOD DRUG ADM
[6]  
*ACOG COMM, 2000, RESP SEARL DRUG WARN
[7]  
*ACOG COMM, 1999, IND LAB MIS
[8]   Oral or vaginal misoprostol administration for induction of labor: A randomized, double-blind trial [J].
Adair, CD ;
Weeks, JW ;
Barrilleaux, S ;
Edwards, M ;
Burlison, K ;
Lewis, DF .
OBSTETRICS AND GYNECOLOGY, 1998, 92 (05) :810-813
[9]   HEALING OF BENIGN GASTRIC-ULCER - A PLACEBO-CONTROLLED COMPARISON OF 2 DOSAGE REGIMENS OF MISOPROSTOL, A SYNTHETIC ANALOG OF PROSTAGLANDIN-E1 [J].
AGRAWAL, NM ;
SAFFOURI, B ;
KRUSS, DM ;
CALLISON, DA ;
DAJANI, EZ .
DIGESTIVE DISEASES AND SCIENCES, 1985, 30 (11) :S164-S170
[10]  
AKDAMAR K, 1982, AM J GASTROENTEROL, V77, P902